1. Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial. (June 2021) Authors: Andrieux-Meyer, Isabelle; Tan, Soek-Siam; Thanprasertsuk, Sombat; Salvadori, Nicolas; Menétrey, Caroline; Simon, François; Cressey, Tim R; Said, Hajjah Rosaida Hj Mohd; Hassan, Muhammad Radzi Abu; Omar, Haniza; Tee, Hoi-Poh; Chan, Wah Kheong; Kumar, Suresh; Thongsawat, Satawat; Thetket, Kanawee; ... Journal: Lancet gastroenterology and hepatology Issue: Volume 6:Number 6(2021) Page Start: 448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients. Issue 1 (26th June 2019) Authors: Sripongpun, Pimsiri; Tangkijvanich, Pisit; Chotiyaputta, Watcharasak; Charatcharoenwitthaya, Phunchai; Chaiteerakij, Roongruedee; Treeprasertsuk, Sombat; Bunchorntavakul, Chalermrat; Sobhonslidsuk, Abhasnee; Leerapun, Apinya; Khemnark, Suparat; Poovorawan, Kittiyod; Siramolpiwat, Sith; Chirapongs... Journal: JGH open Issue: Volume 4:Issue 1(2020) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Real‐world treatment outcomes of sofosbuvir‐based regimens for treatment of chronic hepatitis C with and without human immunodeficiency virus co‐infection. Issue 2 (26th January 2023) Authors: Khemnark, Suparat; Manosuthi, Weerawat Journal: JGH open Issue: Volume 7:Issue 2(2023) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗